Abstract
The quest for the discovery of new antihyperglycaemic agents has been more intense the last years due to the rapid increase of mortality associated with type 2 diabetes. Glycogen metabolism has been one of the major causes of the elevated blood glucose levels; hence, special attention has been drawn to the control of the enzymes implicated in the relevant pathway. To this end, the allosteric enzyme of glycogen phosphorylase, has been proposed as molecular target for the design of potential new antidiabetic agents by an interdisciplinary approach comprising organic synthesis, kinetic and Xray crystallographic studies and physiological experiments. The results derived from the thorough investigation of the catalytic site of the enzyme with the structure-based inhibitor design approach are summarized with emphasis on the most potent inhibitors identified for different classes of compounds.
Keywords: Glycogen phosphorylase, structure-based drug design, type 2 diabetes, X-ray crystallography, β-D-glucopyranosyl analogues, antihyperglycaemic agents, blood glucose levels, D-glucopyranosyl analogues., insulin resistance pathways, glycated hemoglobin, metformin, sulfonylureas, glinides, glucosidase inhibitors, thiazolinidinediones, insulin, gluca-gon-like peptide-1 agonists, amylin agonists, dipeptidyl peptidase-4 inhibitors, hyperglycemia, hypoglycemia, glycogen metabolism, glycogenolysis, glu-coneogenesis, glycogen phosphory-lase, glu-cose-1-phosphate (Glc-1-P), glucose homeostasis, allosteric inhibitors, allosteric activators, Ser14-phosphate recognition site, benzimidazole site, pyridoxal 5, ’, -phosphate, pocket, ANTIDIABETICS, glucopyranose amides, D-glucoseN-Acetyl--D-glucopyranosylamine, D-glucose,, naphthyl group, RMGPb, glucopyranosylidene ana-logues, D-glucopyranosylidene-spiro-oxathiazole, NMR, mass spectrometry
Mini-Reviews in Medicinal Chemistry
Title: The Prototype of Glycogen Phosphorylase
Volume: 10 Issue: 12
Author(s): E. D.Chrysina
Affiliation:
Keywords: Glycogen phosphorylase, structure-based drug design, type 2 diabetes, X-ray crystallography, β-D-glucopyranosyl analogues, antihyperglycaemic agents, blood glucose levels, D-glucopyranosyl analogues., insulin resistance pathways, glycated hemoglobin, metformin, sulfonylureas, glinides, glucosidase inhibitors, thiazolinidinediones, insulin, gluca-gon-like peptide-1 agonists, amylin agonists, dipeptidyl peptidase-4 inhibitors, hyperglycemia, hypoglycemia, glycogen metabolism, glycogenolysis, glu-coneogenesis, glycogen phosphory-lase, glu-cose-1-phosphate (Glc-1-P), glucose homeostasis, allosteric inhibitors, allosteric activators, Ser14-phosphate recognition site, benzimidazole site, pyridoxal 5, ’, -phosphate, pocket, ANTIDIABETICS, glucopyranose amides, D-glucoseN-Acetyl--D-glucopyranosylamine, D-glucose,, naphthyl group, RMGPb, glucopyranosylidene ana-logues, D-glucopyranosylidene-spiro-oxathiazole, NMR, mass spectrometry
Abstract: The quest for the discovery of new antihyperglycaemic agents has been more intense the last years due to the rapid increase of mortality associated with type 2 diabetes. Glycogen metabolism has been one of the major causes of the elevated blood glucose levels; hence, special attention has been drawn to the control of the enzymes implicated in the relevant pathway. To this end, the allosteric enzyme of glycogen phosphorylase, has been proposed as molecular target for the design of potential new antidiabetic agents by an interdisciplinary approach comprising organic synthesis, kinetic and Xray crystallographic studies and physiological experiments. The results derived from the thorough investigation of the catalytic site of the enzyme with the structure-based inhibitor design approach are summarized with emphasis on the most potent inhibitors identified for different classes of compounds.
Export Options
About this article
Cite this article as:
D.Chrysina E., The Prototype of Glycogen Phosphorylase, Mini-Reviews in Medicinal Chemistry 2010; 10 (12) . https://dx.doi.org/10.2174/1389557511009011093
DOI https://dx.doi.org/10.2174/1389557511009011093 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current and Future Therapeutic Strategies in NAFLD
Current Pharmaceutical Design Current Reviews on Renal Vein Thrombosis in Neonates
Current Pediatric Reviews Green Tea Polyphenols as an Anti-Oxidant and Anti-Inflammatory Agent for Cardiovascular Protection
Cardiovascular & Hematological Disorders-Drug Targets Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations
Current Drug Targets Editorial (Hot Topic: Antioxidant Heterocyclic Compounds in Drug Discovery and Medicinal Chemistry)
Mini-Reviews in Medicinal Chemistry Novel Inflammatory Markers in Hyperlipidemia: Clinical Implications
Current Medicinal Chemistry Structure Based Lead Optimization Approach in Discovery of Selective DPP4 Inhibitors
Mini-Reviews in Medicinal Chemistry Hypertriglyceridemia: An Infrequent, Difficult-to-predict, Severe Metabolic and Vascular Problem Associated with Estrogen Administration
Current Vascular Pharmacology FoxO Proteins: Regulation and Molecular Targets in Liver Cancer
Current Medicinal Chemistry Multiple Drug Targets in the Management of Type 2 Diabetes
Current Drug Targets Pathophysiology of Type 2 Diabetes in Children and Adolescents
Current Diabetes Reviews Targeting Gender Difference in the Introduction of New Drugs for Diabetes Mellitus and Metabolic Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery HIV-1 Infection: Recent Developments in Treatment and Current Management Strategies
Anti-Infective Agents in Medicinal Chemistry Genetic Polymorphism and Tumor Immunotherapy
Current Pharmacogenomics Insulin Secretagogues, Sulfonylurea Receptors and KATP Channels
Current Pharmaceutical Design Approaches and Recent Trends in Gene Delivery for Treatment of Atherosclerosis
Recent Patents on Drug Delivery & Formulation Association of Dietary Patterns with Glycated Hemoglobin <i>(HbA1c)</i> among Type 2 Diabetes Patients: A Cross-sectional Study
Current Nutrition & Food Science Cognitive Dysfunction in Major Depressive Disorder: A State-of-the-Art Clinical Review
CNS & Neurological Disorders - Drug Targets Glucagon-Like Peptide-1-Mediated Modulation of Inflammatory Pathways in the Diabetic Brain: Relevance to Alzheimer’s Disease
Current Alzheimer Research Apolipoprotein B and Apolipopotein A-I in Vascular Risk Prediction-A Review
Current Pharmaceutical Design